FORWARD PHARMA A/S's ticker is FWP and the CUSIP is 34986J105. A total of 31 filers reported holding FORWARD PHARMA A/S in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $16,000 | -33.3% | 13,800 | -55.2% | 0.00% | – |
| Q4 2018 | $24,000 | -81.0% | 30,774 | -44.5% | 0.00% | – |
| Q3 2018 | $126,000 | -74.8% | 55,400 | -73.7% | 0.00% | – |
| Q2 2018 | $500,000 | +77.3% | 210,300 | +61.6% | 0.00% | – |
| Q1 2018 | $282,000 | -60.3% | 130,100 | -32.6% | 0.00% | -100.0% |
| Q4 2017 | $711,000 | -35.6% | 193,100 | +6.2% | 0.00% | 0.0% |
| Q3 2017 | $1,104,000 | +239.7% | 181,900 | +962.5% | 0.00% | 0.0% |
| Q4 2015 | $325,000 | -5.0% | 17,120 | +18.1% | 0.00% | 0.0% |
| Q3 2015 | $342,000 | +51.3% | 14,500 | +143.9% | 0.00% | 0.0% |
| Q2 2015 | $226,000 | – | 5,944 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,387,853 | $28,215,000 | 4.38% |
| SENZAR ASSET MANAGEMENT, LLC | 652,500 | $13,265,000 | 3.27% |
| Baupost Group | 6,364,059 | $129,381,000 | 1.48% |
| Assured Investment Management LLC | 1,511,043 | $26,982,000 | 0.56% |
| Perceptive Advisors | 194,718 | $3,959,000 | 0.20% |
| Rhenman & Partners Asset Management AB | 36,584 | $744,000 | 0.11% |
| DRW Securities, LLC | 17,000 | $346,000 | 0.06% |
| NJ State Employees Deferred Compensation Plan | 15,000 | $305,000 | 0.06% |
| Freedom Investment Management, Inc. | 20,178 | $410,000 | 0.02% |
| Acrospire Investment Management LLC | 942 | $19,000 | 0.02% |